Intratumoral Delivery of a PD-1-Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade.

Lin C, Ren W, Luo Y, Li S, Chang Y, Li L, Xiong D, Huang X, Xu Z, Yu Z, Wang Y, Zhang J, Huang C, Xia N
Cancer Immunol Res. 2020 May;8(5):632-647. doi: 10.1158/2326-6066.CIR-19-0628. Epub 2020 Mar 3. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.